GOSS - Gossamer Bio Inc. (GOSS) CEO Faheem Hasnain on Q2 2021 Results - Earnings Call Transcript

Gossamer Bio, Inc. (GOSS) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Bryan Giraudo - Chief Financial Officer Faheem Hasnain - Chairman, Co-Founder and Chief Executive Officer Richard Aranda - Chief Medical Officer Conference Call Participants Joseph Schwartz - SVB Leerink Olivia Brayer - Bank of America Merrill Lynch Patrick Trucchio - H.C. Wainwright Emma Nealon - Cantor Fitzgerald Presentation Operator Good day and thank you for standing by. Welcome to the Gossamer Bio Q2 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] And I would now like to turn the call over to your first speaker, Bryan Giraudo, Chief Financial Officer. You may begin your conference. Bryan Giraudo Thank you, operator and thank you all for joining us this afternoon. I'm joined on today's call by; Gossamer Bio's

For further details see:

Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q2 2021 Results - Earnings Call Transcript